ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2784

Multi Modal Imaging Algorithm to Improve the Accuracy for the Diagnosis of Giant Cell Arteritis

Augustin Lecler1, Thomas Sené2, Herve Picard3, Tifenn Leturcq2, Kevin Zuber3, Frederique Charbonneau1, Catherine Vignal-Clermont4 and Gaelle Clavel2, 1Department of Radiology, Fondation Ophtalmologique A. de Rothschild, Paris, France, 2Internal Medecine, Fondation Ophtalmologique A. de Rothschild, Paris, France, 3Clinical Research Unit, Fondation Ophtalmologique A. de Rothschild, Paris, France, 4Ophtalmology, Fondation Ophtalmologique A. de Rothschild, Paris, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: diagnosis, giant cell arteritis and ultrasound, MRI

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Giant Cell Arteritis (GCA) is the most common systemic vasculitis in patient over 50 years of age. It is a medical emergency as it may lead to ischemic complications, including permanent visual loss in 20 % of untreated patients. Early diagnosis enabling a rapid initiation of treatment is of critical importance. Positive Temporal Artery Biopsy (TAB) is still the gold standard test. However, a negative TAB does not rule out the disease. Encephalic high-field MRI, temporal arteries ultrasonography (US) or fluorescein and indocyanine green angiogram (FA) have been widely studied as diagnostic tests. However, there is currently no consensus nor clearly identified algorithm for their use in a current practice, either alone or in combination.

Our objective was to develop a new multimodal imaging algorithm based on a combination of encephalic high-field (3T) MRI, ultrasonography (US) and retinal angiogram (fluorescein (FA) and indocyanine green (ICGA)) , to improve the diagnosis of GCA

Methods:

All patients referred for suspected GCA at our center from December 2014 to October 2017 were prospectively included in this study. The study was approved by an official external Ethical Review Board. PatientÕs informed consent was obtained upon inclusion.

For each patient, encephalic 3T MRI, cervical and temporal arteries US and retinal angiogram (RA) were performed. Subsequently, a TAB was performed.

TAB-positive patients were considered cases of GCA ; TAB-negative patients files were reviewed by two experts in internal medicine to determine whether they were  or not cases of GCA based on ACR criteria.

Diagnostic accuracy of the combination of MRI, US and RAwas statistically evaluated, first separately for each imaging modality, then using a multimodal classification tree.

Results:

Forty five patients were included. GCA was diagnosed in 25 patients, TAB was positive in 19 patients. Thirty one patients presented a partial vision loss. MRI was positive in 24/44 patients, negative in 16/44 patients and uncertain in 4/44 cases. No patients with negative MRI had GCA. When MRI was positive, 23/24 patients had GCA. If MRI was uncertain and both US and RA were negative, final diagnosis was no GCA ; if either US and/or RA was positive, final diagnosis was GCA. We propose the following algorithm, with a positive predictive value of 96.2 % and a negative predictive value of  100%.

cropped.jpg

Conclusion:

We propose an algorithm that is highly predictive for GCA diagnosis and can be a valuable tool in suspected cases of GCA.

When GCA is suspected, we suggest to perform 3T encephalic MRI first and if uncertain, to add US and RA.


Disclosure: A. Lecler, None; T. Sené, None; H. Picard, None; T. Leturcq, None; K. Zuber, None; F. Charbonneau, None; C. Vignal-Clermont, None; G. Clavel, None.

To cite this abstract in AMA style:

Lecler A, Sené T, Picard H, Leturcq T, Zuber K, Charbonneau F, Vignal-Clermont C, Clavel G. Multi Modal Imaging Algorithm to Improve the Accuracy for the Diagnosis of Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/multi-modal-imaging-algorithm-to-improve-the-accuracy-for-the-diagnosis-of-giant-cell-arteritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multi-modal-imaging-algorithm-to-improve-the-accuracy-for-the-diagnosis-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology